Vanguard discloses 0% Innoviva holding (NASDAQ: INVA)
Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
Innoviva Inc: The Vanguard Group filed Amendment No. 10 to its Schedule 13G/A stating that, following an internal realignment on January 12, 2026, Vanguard and certain subsidiaries will report beneficial ownership separately. The filing reports 0 shares beneficially owned (0% of the class) of Innoviva common stock. The filing lists Vanguard's address and is signed by Ashley Grim, Head of Global Fund Administration dated 03/27/2026.
Positive
- None.
Negative
- None.
FAQ
What does The Vanguard Group report for INVA in Amendment No. 10?
The filing reports 0 shares beneficially owned of Innoviva common stock, representing 0% of the class. The statement follows an internal realignment and disaggregation of beneficial ownership on January 12, 2026 as described in the amendment.
Why did Vanguard change how it reports ownership for INVA?
Vanguard describes an internal realignment on January 12, 2026 and states subsidiaries/divisions will report beneficial ownership separately. The filing cites SEC Release No. 34-39538 as the basis for disaggregating prior aggregated reporting.
When was the Amendment No. 10 to the Schedule 13G/A signed for INVA?
The amendment was signed by Ashley Grim, Head of Global Fund Administration on 03/27/2026. The filing includes Vanguard's principal business address at 100 Vanguard Blvd., Malvern, PA.
Does the filing identify any Vanguard subsidiary holding more than 5% of INVA?
No individual person or entity is identified as holding more than 5% in the filing. The amendment states that no one other person's interest in the reported securities exceeds 5% of the class.